A Study to Evaluate the Effect of KarXT on Urological Safety

Part of paid clinical trials in Little Rock, Arkansas.

Sponsor
Bristol-Myers Squibb
Study ID
NCT07221877
Phase
PHASE4
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Xanomeline/trospium chloride — DRUG
    Specified dose on specified days

Study Details

The purpose of this study is to characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia.

Key Dates

Start date
Jan 20, 2026
Status verified
Jun 2026
Primary completion
Dec 30, 2027
Completion
Dec 30, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: KarXT

Primary Outcome Measure

Change from baseline in voiding dynamics (Qmax) over time [ Time Frame: Up to 12 months ]

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
  • First line of the email MUST contain NCT # and Site #.

Locations (13)

FacilityCityStateZIPSite coordinators
Pillar Clinical Research- Little RockLittle RockArkansas72204
Leslie Smith, Site 0017
501-350-3285
Clinical Innovations, Inc. dba CITrialsBellflowerCalifornia90706
Robert Bota, Site 0007
562-748-4999
CenExel CNS - Garden GroveGarden GroveCalifornia92845
David Walling, Site 0006
714-799-7799
ATP Clinical ResearchOrangeCalifornia92866
Gustavo Alva, Site 0016
949-354-5353
Innovative Clinical ResearchLauderhillFlorida33319
Rishi Kakar, Site 0003
786-512-4106
Health Synergy Clinical ResearchWest Palm BeachFlorida33407
Mohammad Nisar, Site 0004
786-831-7303
Pillar Clinical Research -ChicagoChicagoIllinois60641
Roueen Rafeyan, Site 0010
312-865-6336
Uptown Research InstituteChicagoIllinois60640
John Sonnenberg, Site 0005
773-968-9868
IMA Clinical Research Las VegasLas VegasNevada89102
Mustafa Rawaf, Site 0013
702-527-7401
Hassman Research Institute Marlton SiteMarltonNew Jersey08053
Elan Cohen, Site 0002
267-981-8911
Adams Clinical PhiladelphiaPhiladelphiaPennsylvania19104
Cassie Blanchard, Site 0014
631-252-0769
Local Institution - 0001AustinTexas78754
Site 0001
InSite Clinical ResearchDeSotoTexas75115
Benji Kurian, Site 0015
214-497-3151

Find similar trials in Little Rock, AR

By condition

Related Studies